Shao-Lee Lin, Chief Executive Officer at Cue Biopharma, Inc. (CUE), sold 58,258 shares at $26.99 ($1.6M) on 2026-08-12, disclosed to the SEC on 2026-08-14.
Open-market sale of $1.6M CUE by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.99 | 34,225 | $924K | 57.5% |
| 2 | $27.75 | 5,775 | $160K | 10.0% |
| 3 | $27.19 | 5,423 | $147K | 9.2% |
| 4 | $28.11 | 2,375 | $67K | 4.2% |
| 5 | $29.48 | 10,460 | $308K | 19.2% |
| Total | $27.58 avg | 58,258 |
| $1.6M |
| 100% |
| Filing → |
| SLRN | SELL | 2024-01-04 | $158K | — | Filing → |